ATE269710T1 - Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen - Google Patents

Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen

Info

Publication number
ATE269710T1
ATE269710T1 AT98944115T AT98944115T ATE269710T1 AT E269710 T1 ATE269710 T1 AT E269710T1 AT 98944115 T AT98944115 T AT 98944115T AT 98944115 T AT98944115 T AT 98944115T AT E269710 T1 ATE269710 T1 AT E269710T1
Authority
AT
Austria
Prior art keywords
treatment
pharmaceutical composition
inflammatory bowel
bowel disease
disease
Prior art date
Application number
AT98944115T
Other languages
English (en)
Inventor
Jean-Pierre Sachetto
William Jeffery Sandborn
William John Tremaine
Original Assignee
Medeva Europ Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720590.0A external-priority patent/GB9720590D0/en
Priority claimed from GBGB9725346.2A external-priority patent/GB9725346D0/en
Application filed by Medeva Europ Ltd filed Critical Medeva Europ Ltd
Application granted granted Critical
Publication of ATE269710T1 publication Critical patent/ATE269710T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/723—Xanthans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98944115T 1997-09-26 1998-09-25 Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen ATE269710T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9720590.0A GB9720590D0 (de) 1997-09-26 1997-09-26
GBGB9725346.2A GB9725346D0 (en) 1997-11-28 1997-11-28 Pharmaceutical composition for the treatment of inflammatory bowel disease
PCT/GB1998/002899 WO1999016454A1 (en) 1997-09-26 1998-09-25 Pharmaceutical composition for the treatment of inflammatory bowel disease

Publications (1)

Publication Number Publication Date
ATE269710T1 true ATE269710T1 (de) 2004-07-15

Family

ID=26312333

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98944115T ATE269710T1 (de) 1997-09-26 1998-09-25 Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen

Country Status (11)

Country Link
US (1) US7341741B1 (de)
EP (1) EP1017404B1 (de)
JP (2) JP4180791B2 (de)
AT (1) ATE269710T1 (de)
AU (1) AU758501B2 (de)
CA (1) CA2304948C (de)
DE (1) DE69824748T2 (de)
DK (1) DK1017404T3 (de)
ES (1) ES2224428T3 (de)
PT (1) PT1017404E (de)
WO (1) WO1999016454A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012791A1 (en) 1989-04-21 1990-11-01 E.I. Du Pont De Nemours And Company Fungicidal oxazolidinones
US6166024A (en) * 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
EP1012331B1 (de) 1997-07-01 2006-03-29 Isis Pharmaceuticals, Inc. Zusammensetzungen und verfahren zur verabreichung von oligonukleotiden über die speiseröhre
AU745880B2 (en) * 1998-05-21 2002-04-11 Isis Pharmaceuticals, Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
IT1301947B1 (it) * 1998-07-28 2000-07-20 Chiesi Farma Spa Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa
DE19850445A1 (de) * 1998-11-02 2000-05-04 Falk Pharma Gmbh Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
AUPP915099A0 (en) * 1999-03-12 1999-04-15 Monk, Michael Mendel Improved composition for oral administration
FI119429B (fi) * 2002-09-17 2008-11-14 Danisco Hiilihydraattien uusi käyttö ja koostumukset
US8084432B2 (en) * 2003-02-13 2011-12-27 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of pouchitis
WO2006028012A1 (ja) * 2004-09-07 2006-03-16 Hakuto Co., Ltd. 化粧料およびその製造方法
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
AU2009244190B2 (en) * 2008-05-07 2016-02-25 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
SI3121280T1 (sl) * 2008-11-13 2025-08-29 Nogra Pharma Limited Antismiselne sestave in postopki za njihovo izdelavo ter uporabo
GB0823472D0 (en) * 2008-12-23 2009-01-28 Photocure Asa Product
US9402968B2 (en) 2012-07-11 2016-08-02 Mercy Medical Research Institute, Inc. Colorectal delivery device
US9682101B2 (en) * 2013-03-25 2017-06-20 Ferring B.V. Composition for the treatment of disease
KR20200003827A (ko) 2017-04-14 2020-01-10 젤레시스 엘엘씨 장 투과성-관련 장애를 치료 또는 예방하기 위한 조성물 및 방법
WO2021096479A1 (en) * 2019-11-11 2021-05-20 Trim-Edicine, Inc. Treatment for inflammatory bowel disease and radiation-induced intestinal injury

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3924570A1 (de) 1989-07-25 1991-01-31 Henning Berlin Gmbh Pharmazeutische zubereitung zur rektalen verabreichung
AU1587392A (en) 1991-03-15 1992-10-21 Norwich Eaton Pharmaceuticals, Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
DE59202096D1 (de) 1991-06-07 1995-06-08 Byk Gulden Lomberg Chem Fab Pharmazeutische klistierzubereitung.
WO1995016451A1 (fr) 1992-06-22 1995-06-22 Franck Arno Gouchet Comprimes a liberation controlee de 4-asa
FR2692484B1 (fr) * 1992-06-22 1995-06-30 Gouchet Franck Nouvelle forme galenique de 4-asa a liberation controlee.
US5380522A (en) 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
GB9414699D0 (en) * 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
US5691343A (en) 1995-03-30 1997-11-25 Mayo Foundation For Medical Education And Research Use of topical azathioprine to treat inflammatory bowel disorders
US5811388A (en) 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
SE9602644D0 (sv) * 1996-07-04 1996-07-04 Astra Ab New use

Also Published As

Publication number Publication date
DE69824748T2 (de) 2005-08-25
EP1017404A1 (de) 2000-07-12
CA2304948A1 (en) 1999-04-08
PT1017404E (pt) 2004-11-30
US7341741B1 (en) 2008-03-11
JP2001517708A (ja) 2001-10-09
AU758501B2 (en) 2003-03-20
JP2008143914A (ja) 2008-06-26
AU9178098A (en) 1999-04-23
WO1999016454A1 (en) 1999-04-08
DK1017404T3 (da) 2004-11-01
ES2224428T3 (es) 2005-03-01
JP4180791B2 (ja) 2008-11-12
DE69824748D1 (de) 2004-07-29
CA2304948C (en) 2009-12-29
EP1017404B1 (de) 2004-06-23

Similar Documents

Publication Publication Date Title
ATE269710T1 (de) Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen
TWI256389B (en) Novel hPPAR delta agonists and pharmaceutical compositions comprising the same
ATE113604T1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
NL300389I1 (nl) Thiofeensulfonamiden die bruikbaar zijn als carbo-anhydraseremmers.
DE69021214D1 (de) Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
EP0458079A3 (en) Ultrasonic contrast agent, its preparation and application as diagnostic or therapeutic
NL300224I1 (nl) 3-Benzazepinzonen gesubstitueerd met een benzocyclobutyl-of indanylalkyla-minoalkylgroep, bruikbaar voor de behandeling van cardiovasculaire aandoeningen.
YU49354B (sh) Oralne tečne formulacije alendronata
EP0489647A3 (en) N,o-sulfated heparosanes; process to produce the same and pharmaceutical compositions containing them
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
DE69033970D1 (de) Huperzin a analoge verbindungen
MD2196B2 (ro) Criptoficine, procedeu de obţinere, compoziţii farmaceutice pe baza acestora, metodă de inhibare a proliferării celulelor mamiferelor şi metodă de atenuare a stării patologice cauzate de hiperproliferarea celulelor mamiferelor
FR2687401B1 (fr) Derives de la 1,4-dialkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant.
AU541725B2 (en) Substituted 1,2,5-oxadiazole-2-oxides as pharmaceutical activ cpds,their use and medicaments containing them
EP0529931A3 (de) Wassermodifikator
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.
FR2657872B2 (fr) Derive d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques le contenant.
YU48341B (sh) Preparat herbicida
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
FR2684299B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.
FR2673944B1 (fr) Derives de l'1,8-naphtalimide, leur procede de preparation et les compositions pharmaceutiques les contenant.
DE69104058D1 (de) N-[(2-thenoylmerkapto-3-methyl)-butanoyl]-homocysteinthiolacton, verfahren zu seiner herstellung und diese enthaltende pharmaceutische zusammensetzungen.
UA23368A (uk) Використання (1,1-діоксотіолан-3-іл) диктіокарбамату калію як антимікробного засобу
AU2001295839A1 (en) Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa

Legal Events

Date Code Title Description
EEFA Change of the company name
UEP Publication of translation of european patent specification

Ref document number: 1017404

Country of ref document: EP